It has been a bumpy year for crypto, but what if there was a way to invest in the space while dodging the volatility?
Bitcoin Depot hopes to be that stock and announced a $755 million dollar combination with GSR II Meteora Acquisition Corp. in August.
This week, we speak with Brandon Mintz, CEO of Bitcoin Depot. Brandon tells us how Bitcoin Depot has managed to build a crypto business without holding any crypto by serving customers through thousands of Bitcoin-trading cash ATM.
Its recent financial performance has seen it continue to grow through the crypto highs and lows and generate profits in a manner uncorrelated with Bitcoin prices.
GSR II Meteora Co-CEO Gus Garcia also joins to discuss why that fact was so important to his team’s calculus in striking a deal with Bitcoin Depot.
Give it a listen
Launch Two (NASDAQ:LPBBU) has filed for a $200 million IPO that shows how the market has shifted for new issuance since its sister SPAC Launch One (NASDAQ:LPAAU) filed just over a month ago. Both SPACs are underwritten by Cantor Fitzgerald and seeking nominally the same raise at IPO, but Launch Two is overfunding its trust...
FTAC Emerald (NASDAQ:EMLD) has entered into a definitive agreement to combine with crypto fintech firm Fold at an enterprise value of $381 million. Phoenix, Arizona-based Fold provides digital banking services backed by a treasury of Bitcoin that includes FDIC-secured checking accounts as well Bitcoin trading and awards. The combined company is expected to trade on...
At the SPAC of Dawn Dealmakers remain confident that AI is going to play a big role in their M&A processes, but feel unprepared for some the changes, according to a new survey of 225 corporate and 75 private equity transactions professionals. SS&C subsidiary Mergermarket generated the report that found more than half of respondents...
Trailblazer Merger I (NASDAQ:TBMC) has entered into a definitive agreement to combine with data intelligence firm Cyabra at an enterprise value of $70 million. Tel Aviv-based Cyabra provides tools to corporations and governments to identify fake accounts and combat social media disinformation. The combined company is expected to trade on the Nasdaq once the deal...
Chain Bridge I (NASDAQ:CBRG) has entered into a definitive agreement to combine with cannabinoid pharmaceuticals firm Phytanix Bio at a pre-deal valuation of $58 million. Santa Barbara, California-based Phytanix is working to develop bladder and seizure treatments using cannabis-based substances. The combined company is expected to trade on the Nasdaq under the symbol “PHYX” once...